Fairway Independent Mortgage Named #1 Workplace in the U.S.
MADISON, Wis.–(BUSINESS WIRE)–#mortgage—Fairway Independent Mortgage Corporation, a top-ten nationwide mortgage lender, announced that it won…
News
Wireless Providers Learning to Adapt to Evolving Customer Needs and Expectations, J.D. Power Finds
T-Mobile, Cricket and Consumer Cellular Rank Highest in Respective Segments TROY, Mich.–(BUSINESS WIRE)–Satisfaction with wireless…
The Value of Austin’s Housing Market Surged Nearly 40% in the Past Year—Twice as Fast as the U.S.
The total value of U.S. homes soared 19% year over year to $39 trillion in…
Medical Properties Trust, Inc. Reports Fourth Quarter and Full-Year Results
Per Share Net Income of $0.34 and Normalized FFO of $0.47 in Fourth Quarter Robust…
BlazeMeter by Perforce Revolutionizes Testing with Built-in Test Data Generation
Latest BlazeMeter release accelerates testing and quickly creates test data for functional, performance, and virtual…
Infovista launches 360° Assurance solutions to deliver predictive, real-time and ubiquitous customer experience assurance across any operator’s entire network
Customer experience driven solutions deliver proactive service management and pre-integrated use-case based assurance solutions for…
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
NEW YORK and SAN DIEGO, Feb. 03, 2022 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq:…
Freeline Appoints Henning R. Stennicke, PhD, as Chief Scientific Officer to Lead Research and Discovery
Stennicke, an industry veteran, will join Freeline to lead the research and advancement of the…
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., Feb. 03, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…
Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates
Collaboration focused on discovering novel ADCs for three targets by leveraging Mersana’s ADC expertise and…
ProMIS Neurosciences Appoints Renowned Neuroscientists, Dr. Guy Rouleau and Dr. Alain Dagher to its Scientific Advisory Board
TORONTO, Ontario and CAMBRIDGE, Mass. , Feb. 03, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc….
Trevena to Present at the 2022 BIO CEO & Investor Conference
CHESTERBROOK, Pa., Feb. 03, 2022 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company…
Pardes Biosciences Announces FDA Clearance of IND Application for PBI-0451, an Oral Antiviral Drug Candidate for the Treatment and Prevention of SARS-CoV-2 Infections
CARLSBAD, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage…
Alfred W. Sandrock, Jr., M.D., Ph.D. Appointed to Voyager Therapeutics’ Board of Directors and Newly Formed Executive Committee
Al Sandrock Al Sandrock, Executive Committee Member at Voyager Therapeutics TRACER Capsid Discovery Platform TRACER…
ImCheck Announces First Patients Dosed in Phase II of EVICTION Trial for ICT01
ImCheck Announces First Patients Dosedin Phase II of EVICTION Trial for ICT01 EVICTION trial…
Xilio Therapeutics to Participate in the Guggenheim 4th Annual Oncology Day
WALTHAM, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology…
ProntoForms Announces that Fortune 500 Medical Device Customer Adds Over 3500 Subscriptions and Enables Over 9000 Globally
The solution empowers cross-geographical preventative maintenance service on individual devices OTTAWA, Feb. 03, 2022 (GLOBE…
HanesBrands Announces Strong Fourth-Quarter and Full-Year 2021 Results Driven by Full Potential Growth Plan; Raises 2024 Full Potential Financial Targets; Announces $600 Million Share Repurchase Authorization
Net sales from continuing operations of $1.75 billion, up 4% over fourth-quarter 2020; up 9%…
Uppsala University Hospital Selects Proscia to Deliver Full-Scale Digital Pathology Adoption
Multi-year agreement will power 100% digitization of Uppsala’s clinical workflow and future AI integrations UPPSALA,…
ConocoPhillips Reports Fourth-Quarter and Full-Year 2021 Results; Increases Planned 2022 Return of Capital to $8 Billion and Declares Quarterly Dividend and Variable Return of Cash Distribution
HOUSTON–(BUSINESS WIRE)–ConocoPhillips (NYSE: COP) today reported fourth-quarter 2021 earnings of $2.6 billion, or $1.98 per…